[Treatment of Parkinson syndromes with L-Dopa and the association of L-Dopa and a decarboxylase inhibitor].
作者信息
Guillard A
出版信息
Brux Med. 1972 Oct;52(10):673-80.
PMID:4656191
Abstract
摘要
相似文献
1
[Treatment of Parkinson syndromes with L-Dopa and the association of L-Dopa and a decarboxylase inhibitor].
Brux Med. 1972 Oct;52(10):673-80.
2
[Therapy of Parkinson's syndrome with L-dopa and a decarboxylase inhibitor (Ro 4-4602). Course in 71 patients].
Schweiz Med Wochenschr. 1972 Jan 22;102(3):88-94.
3
[Indications and results of monoamine treatment in parkinsonian syndromes].
Rev Neurol (Paris). 1972 Jul;127(1):79-97.
4
[Comparison of the effect of L-Dopa and of an L-Dopa+decarboxylase inhibitor combination in Parkinson's disease].
Arch Psychiatr Nervenkr (1970). 1973 Mar 19;217(1):95-112. doi: 10.1007/BF02552835.
5
[Experiences in the treatment of Parkinson's disease with a combination drug: L-dopa plus decarboxylase inhibitor (Ro 8-0576)].
Wien Med Wochenschr. 1973 Jun 30;123(26):433-5.
6
[L-dopa therapy of Parkinson's syndrome. Comparison of pure L-dopa and the combination preparation L-dopa and decarboxylase inhibitor].
Dtsch Med Wochenschr. 1972 Aug 25;97(34):1246-8. doi: 10.1055/s-0028-1107539.
7
[Cardiovascular effects of L-dopa and decarboxylase inhibitor on patients with Parkinson's disease].
Schweiz Med Wochenschr. 1973 Dec 15;103(50):1783-5.
8
Treatment of parkinsonism with levo-dopa: results in 302 cases.
Mich Med. 1971 Sep;70(22):805-11.
9
[Therapy of Parkinsonism using L-dopa in combination with a decarboxylase inhibitor].
Fortschr Neurol Psychiatr Grenzgeb. 1972 Oct;40(10):564-8.
10
[Collateral effects of L-dopa treatment in patients with parkinsonism].
Sist Nerv. 1970 Mar-Jun;22(2):109-14.
Zotero 插件